Seeking Alpha

Thomas Barnard's  Instablog

Thomas Barnard
Send Message
Every investment has a trajectory. There is no such thing as static. Investments grow in size until they become really enormous at which point they can only grow along with GDP. To a certain extent picking investments is a little like duck hunting, you want to pick investments which will... More
My company:
Business Risk Management, Inc.
My blog:
Thomas Barnard
My book:
The Intelligence Break
View Thomas Barnard's Instablogs on:
  • Gold's Underpinnings May Turn Out to Be Weak
    It seems an easy momentum call to invest in gold, yet there may be a dramatic revision.  The gold bugs have bloomed again, and the advertisements for cashing in your gold jewelry are everywhere.  For those of us who have lived long enough, that was a good time to sell.  I can remember a silver service that in 1979 was suddenly insured for $20,000 before the collapse, when it got reappraised back to the same price it was purchased for.

    Gold seems to go up on Fed news, and seems to ignore the rest of the economic news.  But TARP, which was supposed to be the government printing money again, has all but been paid back.  And it may turn out that the Fed is not a mad hatter, after all.  And bonds it is buying today, it may sell tomorrow.

    GM successfully did its IPO, and again the government has been paid back.

    The principal problem with gold as inflation hedge is unemployment, which is logged in at 9.5% in the official statistics, but is probably over 15% and could be over 20%, according to Shadow Government Statistics.  This will be a very potent and persistent downward force on the price of goods.

    And the main effect of unemployment is in home pricing.  Foreclosures hit a new record in the third quarter, up to 2.45% of all prime fixed rate loans.  And the Fed's action is an attempt to try and stabilize home prices, because if home prices end up in a tailspin, then it will be cash and not gold that will be the big winner.

    For those in love with gold, every piece of news is an occasion to own more gold.  It's a inflation hedge, a deflation hedge, it's a partridge in a pear tree.  Nevertheless, after the economic problems in the late 1970s, early 80s, gold collapsed, and remained there for decades. 

    In the late 1970s gold got up to $750, but two decades later it still had trouble getting up to $300.  I would be leery of graphs showing the 1970-1980, and graphs showing 2000-2010, when all the action is up.  No matter what the argument, we are probably nearer to the end of the cycle than the beginning of the cycle, and as the recent events in Chile remind us, mines can collapse.







    Disclosure: Long GG
    Tags: NEM, GG, GLD, ASA, GOLD, FCX, AU, ABX
    Nov 18 2:01 PM | Link | Comment!
  • Big Pharma Not Ignoring Generex After All
    I have been wondering where Big Pharma has been while tiny Generex (OTCQB:GNBT) has been plowing ahead with industry changing technologies.  Namely, it's buccal delivery of drugs with its test case of insulin, and its cancer vaccine technology.

    Today, August 5, 2010, Generex announced that Dr. Craig Eagle will be joining its scientific advisory board.  Dr. Eagle was raised in Australia, and in 2001 joined Pfizer Australia.  He is expert in oncology, and was brought to the U.S. in 2003, and is the head of oncology therapeutics at Pfizer (PFE).  He will bring his expertise to the trials Generex is conducting with its AE37 vaccine on prostate and breast cancers.  This is good news for cancer sufferers everywhere, and good news for Generex shareholders.

    I have asked where Big Pharma has been for months with regard to Generex, and now I have my answer.  They are on the case.

    I don't pay much attention to technical signals, but I rate this a fundamental buy signal, albeit a speculative one, since we don't have any Phase III completions.  Pfizer should be interested.  I thought they would be paying more attention to the insulin delivery system, but I'm going to take this announcement as awareness of all of the company's potential.  This focus on the vaccine technology of Generex reinforces that the company has the depth.  It is a double threat, but it will only take one of the technologies to work to make shareholders wealthy.




    Disclosure: Long GNBT
    Tags: PFE, GNBT
    Aug 06 12:16 AM | Link | 3 Comments
Full index of posts »
Latest Followers

Latest Comments


Most Commented
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.